Woven Orthopedic Technologies LLC
Biotextile strengthens screw fixation in compromised bone
This article was originally published in Start Up
Executive Summary
One of the biggest challenges with orthopedic screws is inadequate fixation in poor quality bone; the revision rate of requiring a second surgery for loss of screw engagement is 15%. Woven Orthopedic Technologies LLC hopes to significantly reduce that rate with its braided polymer that is placed into a screw hole to provide good fixation within the entire bone.
You may also be interested in...
The A-List: The Trend-Shaping Series A Financings Of 2015
Our 12th annual analysis reveals both an expansion of historical patterns of Series A financings and the emergence of a new group of heavily committed, relatively short-term investors.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.